Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1698 studies found for:    "Depressive Disorder" [DISEASE] | "Depressive Disorder, Major"
Show Display Options
Rank Status Study
21 Completed An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: saredutant (SR48968);   Drug: paroxetine;   Drug: placebo
22 Completed Whole Body Hyperthermia and Major Depression (MDD)
Condition: Depressive Disorder, Major
Intervention: Device: Whole Body Hyperthermia system
23 Completed Major Depressive Disorder In The Elderly
Condition: Depressive Disorder, Major
Intervention: Drug: bupropion XL
24 Suspended Predictors of Treatment Response in Late-onset Major Depressive Disorder
Condition: Depressive Disorder, Major
Intervention: Drug: Standard care
25 Recruiting Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Ketamine IV Infusion;   Procedure: ECT
26 Completed Study Of GW679769 In Major Depressive Disorder
Conditions: Depressive Disorder, Major;   Major Depressive Disorder (MDD)
Intervention: Drug: GW679769
27 Recruiting Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Bupropion;   Drug: Bupropion Matching Placebo;   Drug: Escitalopram;   Drug: Escitalopram Matching Placebo
28 Completed Major Depressive Disorder Study In Adults
Condition: Major Depressive Disorder
Intervention: Drug: paroxetine CR
29 Terminated Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: ABT-436;   Drug: Escitalopram;   Drug: Placebo
30 Completed
Has Results
A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom
Condition: Depressive Disorder, Major
Intervention: Drug: Escitalopram
31 Active, not recruiting Blood Biomarkers in Major Depression
Condition: Major Depressive Disorder
Interventions: Other: blood prelevement;   Other: psychometric data collection
32 Completed Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: DVS-233 SR
33 Withdrawn The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Agomelatine;   Drug: Fluoxentine
34 Completed
Has Results
A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD)
Condition: Depressive Disorder, Major
Interventions: Drug: 323U66 SR 150 mg tablet;   Drug: 323U66 SR 150 mg placebo tablet
35 Completed Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: desvenlafaxine 50 mg;   Drug: desvenlafaxine 100 mg
36 Completed
Has Results
Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Desvenlafaxine Succinate Sustained-Release 10mg;   Drug: Desvenlafaxine Succinate Sustained-Release 50 mg;   Drug: placebo
37 Completed
Has Results
Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Desvenlafaxine succinate sustained release 50 mg;   Drug: Desvenlafaxine succinate sustained release 25 mg;   Drug: Placebo
38 Completed
Has Results
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Desvenlafaxine Succinate Sustained-Release (DVS SR);   Drug: placebo
39 Completed Safety Study of F2695 SR in Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: F2695 SR
40 Completed A Study to Investigate the Effect of JNJ-42847922 on Polysomnography Measures in Patients With Major Depressive Disorder With Insomnia Who Are Stably Treated With Antidepressants
Condition: Depressive Disorder, Major
Interventions: Drug: JNJ-42847922;   Other: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.